Abstract. The experimental procedures to simultaneously detect contractile activity and Ca
Introduction
The cardiac pump is able to alter its function immediately in response to the requirement for blood supply to vital organs in the body by means of alteration of myocardial contractility. Cardiac myocytes act as a functional syncytium and all cells are excited simultaneously to contribute to maintenance of pump function, which is in strong contrast to skeletal muscle fibers. Therefore, the regulation of contractile function of individual myocytes achieved by modulation of intracellular Ca 2+ signaling in individual cardiac myocytes plays a crucial role in adaptation of cardiac pump function in vivo.
In ] i , troponin I inhibits the interaction of thin (actin, troponin subunits, tropomyosin) and thick (myosin) filaments. Ca 2+ ions released via the CICR mechanism diffuse through the cytosolic space to contractile proteins to bind to troponin C resulting in the release of inhibition induced by troponin I. The Ca 2+ binding to troponin C thereby triggers the sliding of thin and thick filaments, that is, the activation of a crossbridge and subsequent cardiac force development and/ or cell shortening. Subsequent to the elevation and contractile activation, the [Ca 2+ ] i is returned to diastolic levels mainly by activation of the SR Ca 2+ pump (SERCA2a) and sarcolemmal (SL) Na + / Ca 2+ exchanger (NCX), and partly by the SL Ca 2+ pump. Thus, the transient increase in [Ca 2+ ] i (Ca 2+ transient), which occurs subsequent to membrane excitation (the fast rising phase of an action potential) preceding force development or cell shortening, plays a key role in cardiac excitation-contraction (E-C) coupling by determining the amount of Ca 2+ ions to bind to troponin C (Fig. 1) .
Measurement of Ca 2+ transients simultaneously with alteration of contractile function in intact contracting myocardium and / or single cardiac myocytes is an excellent procedure for differentiating the site of action of inotropic interventions. The regulatory mechanisms of cardiac E-C coupling in respect to Ca 2+ signaling are classified into three processes: an upstream mechanism that increases intracellular Ca 2+ mobilization and thereby Ca 2+ transients; a central mechanism that plays a key role in cardiac E-C coupling by triggering crossbridge cycling by Ca 2+ binding to troponin C; and a downstream mechanism that involves the thin filament regulation of troponin C or crossbridge cycling and direct activation of the crossbridge (Fig. 1 ). It should be noted, however, that these mechanisms interact with each other to regulate myocardial contractility in intact myocardium. For example, activation of the upstream mechanism results in the activation of a central mechanism because the increase in force by increased number of crossbridges leads to an increase in Ca 2+ binding affinity of troponin C, which constitutes a positive feedback mechanism. Therefore, the alteration of Ca 2+ transients induced by a pure elevation of extracellular Ca 2+ concentration ([Ca 2+ ] o ) can be used as the standard to compare with the effects of various inotropic interventions (1) .
Cardiac myocytes are equipped with intrinsic regulatory mechanisms and regulated also by external regulatory mechanisms triggered via SL receptor activation induced by neurohumoral interventions. Intrinsic regulatory mechanisms are exerted by the property pertained by the myocardial cell itself, including the FrankStarling mechanism and the force-frequency relationship, while the external regulatory mechanisms involve neurohumoral regulation induced by activation of SL receptors, for example, β-and α-adrenoceptors, angiotensin II (Ang II), endothelin (ET), cytokine receptors, and cardiotonic agents such as Ca 2+ mobilizers and Ca
2+
sensitizers. A pronounced dissociation of contractile function from Ca 2+ transients occurs by certain cardiotonic agents such as α-adrenoceptor agonists, Ang IIand ET-receptor agonists, Ca 2+ sensitizers, and under pathophysiological conditions such as acidosis, stunned myocardium, and heart failure. ] i in intact myocardium. A multicellular preparation of cardiac muscle loaded with aequorin by a microinjection or chemical loading procedure can be fixed in an organ bath in the dark room, and superperfused with oxygenated Krebs-Henseileit solution at 37°C. Contractile force and aequorin light signals are recorded simultaneously. An aequorin-loaded multicellular preparation has advantages in that the aequorin light signals can be sensitively and stably detected in intact muscle preparations with minimal movement artifact and with intact physiological regulatory processes modulated through physiological pathways or activated by external inotropic interventions. The contractile response can be detected under ideal experimental conditions in which the muscle is stretched to a length close to the muscle length at which the contractile force is maximal (L max ) and the drug response is not altered by aequorin loading. On the other hand, disadvantages include hazardous procedures of aequorin loading and requirement of signal averaging. It should be noted that much larger numbers of cells contribute to the force development than the cells from which the aequorin signals are measured. Furthermore, the aequorin light signals do not directly reflect the Ca 2+ concentration in the vicinity of troponin C but do reflect the alteration of cytosolic Ca 2+ concentration, which is supposed to represent the former; however, contributions of unknown processes including hindrance to Ca 2+ diffusion cannot be excluded. While in myocardial cells aequorin may be distributed freely and evenly throughout the cytosolic space, it is postulated in smooth muscle cells that aequorin distribution is limited to a space narrower than that where indo-1 is distributed (4).
Experimental procedures
Single cardiac myocytes loaded with Ca 2+ sensitive fluorescent dyes, such as indo-1, fura-2, fluo-3, and so on, are currently used more and more because of the ease of loading procedures. Although these experimental methods provide elegant experimental preparations, the signals obtained from these preparations have to be analyzed with careful consideration. Fluorescent signals are unstable and the diastolic signal levels exceed the 
peak of Ca
2+ transients when the frequency of stimulation is raised, which occurs only rarely with aequorinloaded preparations. Furthermore, single myocytes are contracting (shortening) from the slack length, which is far from an ideal condition for measurement of mechanical responses to inotropic interventions. To overcome these disadvantages, it is useful to carry out the study by simultaneously comparing the drug response of Ca 2+ signals in single and multicellular preparations (5 -8 ] o is elevated stepwise, the amplitude of Ca 2+ transients and contractile force are increased in parallel and the relationship of both parameters is linear as demonstrated in the rabbit as well as dog ventricular myocardium (9, 10).
Intrinsic regulatory mechanisms
Two major intrinsic regulatory mechanisms that are essential for the immediate adjustment of cardiac contractile function to rapidly changing requirements of blood supply to the body are the Frank-Starling mechanism and the force-frequency relationship. The contrasting processes of cardiac Ca 2+ signaling are responsible for the respective regulation: the former is primarily achieved by the downstream mechanism, whereas the latter is due to activation of the upstream mechanism in intact myocardial cells (11, 12) .
4-1. Frank-Starling mechanism
The Frank-Starling mechanism reflects basic myocardial contractility represented by the length-tension relationship in isolated cardiac muscle and the ventricular function curve in experimental animals and patients. When the contractile force is markedly altered depending on the extent of stretch of the cardiac muscle, the aequorin light signal at L max is slightly abbreviated compared with that at slack length, probably because of the feedback mechanism, that is, an increase in Ca 2+ binding affinity induced by the force development (1). However, the amplitude of Ca 2+ transients is essentially identical during operation of the Frank-Starling mechanism. It is generally accepted that the ventricular function curve reflects cardiac pump function, which fluctuates widely with various pathophysiological situations from the super-normal in hyperthyroidism to an aggravated state depending on the extent of severity of contractile dysfunction. Two potential mechanisms have been proposed to be underlying the Frank-Starling mechanism. First, the optimum extent of thin and thick filaments overlapping for force development is believed to play an essential role (longitudinal hypothesis). The second hypothesis of an abbreviated distance between actin and the myosin head with stretch (lateral hypothesis) has also been proposed. In addition, aggravation of the Frank-Starling mechanism in muscle isolated from the heart failure model animal or patients may be ascribed to the dysfunction of the upstream mechanism because cardiotonic agents such as digitalis can reverse the deteriorated Frank-Starling mechanism.
4-2. Force-frequency relationship
When the rate of contraction in mammalian ventricular myocardium is increased over the physiological range, the contractile force is increased in most species, which has been recognized and documented as the forcefrequency relationship. It is another important intrinsic regulatory mechanism of myocardial contractility (13) . In contrast to the Frank-Starling mechanism, the positive force-frequency relationship in ventricular myocardium observed in most mammalian species is primarily due to a frequency-dependent increase in the amplitude of Ca 2+ transients (14) . The increase in Ca 2+ transients is considered to be caused by 1) the prolonged duration of depolarization per unit time, resulting in longer activation in L-type Ca 2+ influx, and 2) the increased accumulation of Na + ions by repetitive excitation per unit time that leads to the elevation of [Ca 2+ ] i by NCX (14) . The positive force-frequency relationship in ventricular myocardium disappears or is inverted to become negative in failing ventricular myocardium in the late stage of congestive heart failure. This phenomenon is ascribed to the dysfunction of Ca 2+ handling, that is, disappearance or inversion of the positive Ca 2+ transientfrequency relationship, which is directly reflected to that of the force-frequency relationship induced by hemodynamic as well as neurohumoral interventions during the course of progress of heart failure. Concerning the subcellular mechanisms of dysfunction of Ca 2+ handling, namely, the essential cause, there are controversial observations supporting the shortage of SR Ca 2+ stores due to down-regulation of Ca 2+ uptake via SERCA2a (15) . On the other hand, some studies realize that the dysfunction of the ryanodine receptor in relation to hyper-phosphorylation of this and other regulatory proteins plays a crucial role in the inverted forcefrequency relationship in heart failure (16) . It has been shown that the agent that increases cAMP such as forskolin can reverse the inverted force-frequency relationship, which means that the upstream mechanism is crucial for the relationship (17).
External regulatory mechanisms
Among diverse physiological and pathophysiological regulatory processes of cardiac Ca 2+ signaling, regulation mediated by sympathetic nerve stimulation (18, 19) and β-adrenoceptors plays the most crucial role as it is activated frequently in physiological conditions, prominently modulates the pathological process of congestive heart failure, and is down-regulated in severe heart failure. Most sympathomimetic amines act predominantly by activation of β-adrenoceptors through accumulation of cAMP, subsequent activation of protein kinase A (PKA), and partially through a cAMP-independent mechanism mediated by activation of cardiac α-adrenoceptors (20 -26) . Phosphodiesterase (PDE) inhibitors elicit the positive inotropic effect via a mechanism similar to that of β-adrenoceptor stimulation because they act by activation of the cAMP/ PKA signaling pathway (27 -43) . A number of agents such as papaverine (27, 28) , cilostamide and isobutylmethylxanthine (29) , amrinone (30), milrinone (32) , vesnarinone (31), OPC-8490 (36), ZSY-39 (33), Ro-1724 (34), olprinone (35) , Y-20487 (37), and UK-1745 (38) belong to the same family, which induce a positive inotropic effect by themselves and are able to enhance the effect of β-adrenoceptor stimulation (except UK-1745). Some of them are very effective in the treatment of cardiac pump dysfunction in acute and decompensated heart failure (39 -43) .
The regulation of Ca 2+ signaling induced by the activation of the receptor family that is coupled to the stimulation of phosphoinositide hydrolysis is characteristically different from that of β-adrenoceptor stimulation. Activation of α-adrenoceptors (44 -64), as well as Ang II AT 1 (65 -69) and ET (70 -83) receptors, causes a characteristic modulation of Ca 2+ signaling including facilitation of intracellular Ca 2+ mobilization in association with an increase in myofilament Ca 2+ sensitivity (9), along with the long-term regulation of cardiac remodeling. In dog ventricular myocardium, ET-1 alone elicited only a small negative inotropic effect, but it modulated Ca 2+ signaling and contractility in a complex manner by crosstalk with norepinephrine (84 -90) .
The activation of muscarinic cholinergic (91 -97) and adenosine (98, 99) receptors induces an important inhibitory regulation of cardiac Ca 2+ signaling. Under pathological conditions, such as myocardial infarction and heart failure, diverse signaling processes triggered by activation of cytokine receptors come into play to regulate pathological features partly through modulation of cardiac Ca 2+ signaling. Cardiotonic agents are of extreme importance to reverse contractile dysfunction in acute and decompensated heart failure, acting through facilitation of Ca 2+ mobilization and / or an increase in myofilament Ca 2+ sensitivity (100 -110). Some Ca 2+ sensitizers are able to elicit a positive inotropic effect even under acidotic conditions and in the failing heart (111 -116).
5-1. β-Adrenoceptor stimulation
β-Adrenoceptor stimulation elicits the most effective increase in contractile function in association with a marked facilitation of Ca 2+ transients and an abbreviation of the Ca 2+ transient that is reflected in a prominent abbreviation of the duration of contraction and an acceleration of relaxation (a positive lusitropic effect). While the β 1 -adrenoceptor, which is the predominant subtype in cardiac muscle, is coupled to activation of adenylyl cyclase through G s proteins, the β 2 -adrenoceptor is coupled to both G s and G i proteins, and thus has regulatory profiles different from those of β 1 -adrenoceptor stimulation. Ca 2+ signal regulation is achieved by cAMP/ PKA signaling, namely serine / threonine phosphorylation of a series of cardiac Ca 2+ regulatory proteins. Facilitation of Ca 2+ transients involves phosphorylation of the following proteins: 1) L-type Ca 2+ channels (an increase in availability of Ca 2+ channels that results in an increased Ca 2+ influx upon membrane depolarization), 2) phospholamban (an activation of SERCA2a due to disinhibition induced by dephosphorylated phospholamban to increase SR Ca 2+ stores and acceleration of decline of Ca 2+ transients), 3) ryanodine receptors (a facilitation of Ca 2+ release from SR). Abbreviation of Ca 2+ transients and acceleration of relaxation are ascribed to phosphorylation of 1) phospholamban and 2) troponin I (a decrease in myofilament Ca 2+ sensitivity). In addition, it has been shown that other functional proteins such as myosin binding protein C and NCX are phosphorylated to potentially contribute to the regulation of Ca 2+ handling (11, 12) . Most sympathomimetic amines such as phenylephrine (20, 23, 24) , dopamine (21, 46) , norepinephrine, epinephrine (46), isoproterenol (22) , dobutamine (25) , and denopamine (26) ] o (9). This may be partly due to a decrease in myofilament Ca 2+ sensitivity in relation to troponin I phosphorylation and abbreviation of Ca 2+ transients due to activation of SERCA2a. Abbreviation of twitch contraction is much more pronounced than that of Ca 2+ transients, which implies a significant contribution of the decrease in Ca 2+ sensitivity induced by catecholamines in relation to troponin I phosphorylation (9).
5-2. α-Adrenoceptor stimulation
α-Adrenoceptors have long been supposed to play an insignificant role in cardiac Ca 2+ signal and functional regulation. However, during the past three decades, α-adrenoceptors have been recognized to play an important role in cardiac regulation including contractile function and remodeling through the cAMP / PKAindependent process. α-Adrenoceptor stimulation has been shown to modulate cardiac Ca 2+ signaling by stimulation of phosphoinositide hydrolysis, resulting in the production of inositol 1,4,5-trisphosphate (IP 3 ) and diacylglycerol that activates protein kinase C (PKC) (54, 55, 60) .
α-Adrenoceptor-mediated regulation of Ca 2+ signaling and cardiac contractility shows characteristics completely different from those mediated by β-adrenoceptors. α-Adrenoceptor-mediated positive inotropic effects show a wide range of species-dependent variation (54, 55, 60) . They are pronounced in the rabbit (45, 50) ; moderate in rat, guinea pig, and monkey (49); least in the ferret (52); and absent in dog ventricular myocardium (47, 48, 63) . In single mouse ventricular myocytes, α-adrenoceptor stimulation decreases Ca 2+ transients and cell shortening (64) .
The α-adrenoceptor-mediated effect is more susceptible to the inhibitory action of Ca 2+ antagonists (53) and is suppressed more easily by elevation of stimulation frequency and experimental temperature than the β-adrenoceptor-mediated effect (44, 55, 60) . Concerning the α-adrenoceptor subtype involved in regulation of Ca 2+ signaling and contractile activity in the rabbit ventricular myocardium, the α 1B -subtype is predominant (approximately 80%), which is susceptible to chlorethylclonidine (56, 59) . Other subtypes, including the α 1A -subtype, which is inhibitable with WB 4101, 5-methylurapidil (57), (+)-niguldipine (58) , and the α 1D -subtype, which is susceptible to BMY 7378 (62) , contribute partially to the contractile regulation in the rabbit. Activation of PKC induced by endogenously generated diacylglycerol may play a crucial role in the α-adrenoceptor-mediated positive inotropic effect. However, externally administered phorbol esters that have an effect to activate PKC in vitro do not mimic, but rather suppress the α-mediated positive inotropic effect by inhibiting the receptor-mediated stimulation of phosphoinositide hydrolysis (51) . Furthermore, the PKC inhibitors suppress only partially the α-mediated effect (60, 61) .
In the rabbit papillary muscle, phenylephrine in the presence of a β-blocker elicits a positive inotropic effect in association with no change in cAMP levels (22, 23) . However, there is an increase in Ca 2+ transients, but much less than that induced by isoproterenol (9) . In contrast to the effect of β-adrenoceptor stimulation, the positive inotropic effect of α-stimulation is accompanied by an increase in Ca 2+ transients much lower than that induced by elevation of [Ca 2+ ] o (9). The relationship of Ca 2+ transients and contractile force is shifted to the left, indicating that α-adrenoceptor stimulation increases myofilament Ca 2+ sensitivity in addition to a moderate increase in Ca 2+ transients (9) . α-Adrenoceptor stimulation elicits a reciprocal effect on the duration of Ca 2+ transients and twitch contraction (9) . This indicates that an increased Ca 2+ binding affinity to troponin C may lead to a prolongation of the duration of contraction, simultaneously decreasing the amount of Ca 2+ ions available for aequorin binding (9) . The maximum contractile response to α-adrenoceptor stimulation is approximately 60% of the maximal response to isoproterenol (ISO max ), whereas that of Ca 2+ transients is only 10% of ISO max , which indicates an increase in Ca 2+ sensitivity induced by α-adrenoceptor stimulation (9). The dopamine-induced positive inotropic effect is ascribed to activation of both β-and α-adrenoceptors (9, 55, 60).
5-3. Ang II
Ang II exerts a positive inotropic effect through activation of AT 1 receptors and subsequent acceleration of phosphoinositide hydrolysis (65, 66) . Activation of PKC by phorbol 12,13-dibutyrate inhibits the Ang IIinduced stimulation of phosphoinositide hydrolysis and thereby the positive inotropic effect of Ang II in rabbit ventricular myocardium (65) . The positive inotropic effect of Ang II shows a wide range of speciesdependent variation, being pronounced in the rabbit ventricular myocardium (66) and is associated with activation of L-type Ca 2+ channels (67, 69), the Na (67, 68) , and NCX (68) . The positive inotropic effect of Ang II is similar to the α-adrenoceptormediated effect, and it is associated with a moderate increase in Ca 2+ transients and an increase in myofilament Ca 2+ sensitivity in rabbit papillary muscle (7) and single ventricular myocytes (68).
5-4. ET
ET isopeptides induce a pronounced positive inotropic effect associated with stimulation of phosphoinositide hydrolysis (71) via predominant activation of ET A receptors (73) in mammalian ventricular myocardium of most species (70, 74, 76) . The positive inotropic effect of ET isopeptides shows a wide range of species-dependent variation. The most pronounced positive inotropic effect is observed in rabbit ventricular myocardium among the species examined; and ET-1, ET-2, and ET-3 exert the effect with an identical efficacy and potency (70) . While the positive inotropic effect of ET-3 (73), and ET-1 at lower concentrations (<10 −8 M) (72) , is susceptible to ET A -receptor antagonists, the ET A -receptor antagonists are unable to shift the main portion of the concentration-response curve for ET-1 in rabbit papillary muscle (72, 76, 81) . The potent ET A -receptor antagonist TAK-044 can inhibit the positive inotropic effect of ET-1 in the rabbit, but a concentration one hundred times higher than that which inhibits the ET-3-induced response is required (83) . ET-1, but not ET-3, shows much higher potency for induction of the positive inotropic effect in rabbit single ventricular myocytes than papillary muscles, the reason for which is currently unknown (81) . The positive inotropic effect of ET-1 is associated with a moderate increase in L-type Ca 2+ current (78) and an increase in myofilament Ca 2+ sensitivity (77, 81) , the latter being susceptible to the inhibitors of the Na + / H + exchanger (80), PKC and tyrosine kinase (82).
5-5. Crosstalk of ET with norepinephrine
In the dog ventricular myocardium, ET-1 alone induces only a small transient negative inotropic effect (8) . However, ET-1 exerts a complex contractile regulation by crosstalk with β-adrenoceptor stimulation induced by sympathomimetic amines such as norepinephrine and isoproterenol (8) . The crosstalk involves diverse signaling pathways (8) . In the presence of weak β-adrenoceptor stimulation induced by low [10 −10 M (sub-threshold) − 10 −9 M (threshold)] concentrations of norepinephrine, ET-1 elicits a long-lasting positive inotropic effect in a concentration-dependent manner in association with a moderate increase in Ca 2+ transients and an increase in myofilament Ca 2+ sensitivity (8, 84) . α-Adrenoceptor stimulation and Ang II likewise elicit a positive inotropic effect in the presence of low concentrations of norepinephrine in canine ventricular myocardium, but the extent of the effect of Ang II is less than ET-1 (86) . The positive inotropic effect of ET-1 requires activation of both PKC and PKA (8) , and it is inhibited by genistein (a tyrosine kinase inhibitor) (87), wortmannin (an MLCK inhibitor at µM concentration) (88) , and Y-27632 (a Rho kinase inhibitor) (90) .
In the presence of high concentrations (approximately 10 −6 M) of norepinephrine, ET-1 elicits a pronounced and long-lasting negative inotropic effect that is associated with a decrease in L-type Ca 2+ current (79) and Ca 2+ transients (8), but with no change in cAMP levels (75) and Ca 2+ sensitivity (8) . The negative inotropic effect of ET-1 is suppressed by treatment with pertussis toxin, a guanylyl cyclase inhibitor (LY83583), a PKG inhibitor (KT5823), and a phosphatase inhibitor (cantharidin) (85) .
The long-lasting positive and transient negative inotropic effect of ET-1 in dog ventricular myocardium is mediated by ET A -receptor activation, while the longlasting negative inotropic effect involves both predominant ET A -and partial ET B -receptor activation (89).
5-6. Muscarinic and adenosine receptor stimulation
Acetylcholine (ACh) acts on muscarinic and nicotinic receptors, resulting in a negative and positive inotropic effect in mammalian ventricular myocardium (91) . Muscarinic receptor stimulation induces activation of dual pathways through activation of G i proteins that are susceptible to pertussis toxin (96) . The activation of potassium channels (I KACh ) leads to an abbreviation of action potential duration and subsequent decrease in the amplitude of Ca 2+ transients, which results in a pronounced negative inotropic effect in atrial muscle but not in mammalian ventricular muscle (8, 97 ). This direct negative inotropic effect is associated with an increase in cGMP levels, mimicked by an increase in cGMP and cGMP analogues (93, 95) . In ferret ventricular myocardium, this inhibitory regulation is exceptionally pronounced among mammalian species and leads to a marked decrease in Ca 2+ transients and a negative inotropic effect even in the absence of β-adrenoceptor stimulation (97) . For a given decrease in Ca 2+ transients, the attenuation of contractile force induced by carbachol is less than that caused by lowering [Ca 2+ ] o . This is an indication that muscarinic receptor stimulation decreases Ca 2+ transients, but may simultaneously increase myofilament Ca 2+ sensitivity (97). In the presence of β-adrenoceptor stimulation, muscarinic receptor stimulation elicits a pronounced negative inotropic effect in ventricular myocardium, which has been well documented as an "anti-adrenergic effect" or "accentuated antagonism" in mammalian ventricular myocardium (97) . This indirect inhibitory effect of muscarinic receptor stimulation is exerted selectively on β-, but not α-adrenoceptor-mediated positive inotropic effect (94) , and is associated with a decrease in cAMP levels in dog ventricular myocardium (92) and a parallel decrease in Ca 2+ transients (8, 97) . The subcellular mechanism is ascribed either to a decrease in cAMP levels through coupling to G i proteins (96) and / or to activation of phosphatase, which dephosphorylates the functional proteins that have been phosphorylated previously by activation of PKA (8) .
Adenosine elicits a differential inhibitory action on the β-mediated effect without affecting the α-adrenoceptor-mediated positive inotropic effect (98, 99) , which is mediated by activation of pertussis toxin sensitive G i proteins (96).
5-7. Cardiotonic agents
Cardiotonic agents, such as catecholamines (e.g., norepinephrine, dobutamine, dopamine, and denopamine) and PDE III inhibitors (e.g., milrinone, amrinone, olprinone, vesnarinone, enoximone, and piroximone), are currently used for the treatment of cardiac contractile dysfunction in patients with acute and decompensated heart failure. Cardiotonic agents increase contractile function by acting at three different steps of cardiac E-C coupling, that is, the upstream, central, and downstream mechanisms (1) . Most of the cardiotonic agents currently available for clinical use induce a positive inotropic effect via the upstream mechanism by facilitating mobilization of [Ca 2+ ] i through activation of different subcellular processes leading to an increase in Ca 2+ transients in intact myocardial cells (Ca 2+ mobilizers). Other classes of agents (Ca 2+ sensitizers) are capable of inducing a positive inotropic effect by increasing the binding affinity of troponin C for Ca 2+ (central) and / or facilitating the thin filament regulation of contractile proteins (troponin C or crossbridge) or direct activation of crossbridge cycling itself (downstream mechanism) (Fig. 1) . 2+ sensitivity of troponin C due to troponin I phosphorylation produce a shift of the relationship to the right. This shift to the right indicates an apparent decrease in Ca 2+ sensitivity (9) . Ca 2+ mobilizers generally suffer from the potential risk of Ca 2+ overload leading to cardiac arrhythmias, cell injury, and ultimate cell death (110).
5-7-2. Ca
2+ sensitizers Current research interests have been focused more on Ca 2+ sensitizers, which could overcome the disadvantages associated with Ca 2+ mobilizers in the therapy of heart failure patients as follows: 1) Ca 2+ sensitizers do not increase the activation energy required for [Ca 2+ ] i handling; 2) they are free from potential risks of arrhythmias, cell injury, apoptosis, and cell death due to Ca 2+ overload; and 3) they have the potential to reverse contractile dysfunction under pathological conditions, such as acidosis, myocardial stunning, and congestive heart failure (104, 110) . Ca 2+ sensitizers can be classified into three classes: class I acting on the central mechanism; class II acting on the thin filament regulation of troponin C and / or crossbridge cycling; and class III directly acting on the crossbridge cycling, depending on the sites and/ or mechanisms of action as shown in Fig. 1 . Differentiation of class I and class II agents require careful analysis because certain agents and inotropic interventions (e.g., EMD 57033 and acidosis) affect the Ca 2+ binding affinity of troponin C (central mechanism) by allosteric regulation via troponin I (Fig. 1) .
It is noteworthy that the currently available cardiotonic agents, such as pimobendan and levosimendan, which act to increase myofilament Ca 2+ sensitivity, also possess PDE III inhibitory action (39 -43) .
In mammalian ventricular myocardium, the muscarinic receptor agonist carbachol is able to abolish the positive inotropic effect of the pure PDE inhibitors including amrinone, milrinone, and olprinone (32) . However, the positive inotropic effects of certain cardiotonic agents such as sulmazole (100), pimobendan (101), pimobendan's active metabolite UD-CG 212 Cl (109), Org 30029, Org 9731 (102, 103) , SCH 00013 (105), and EMD 57033 are partially resistant to the inhibitory action of carbachol. These agents exert a positive inotropic effect without an increase in Ca 2+ transients acting via central and / or downstream mechanisms in the presence of carbachol (32, 104, 110) .
More recently, it has been found that carbachol abolishes the positive inotropic effects of levosimendan (5, 116) and its active metabolite OR-1896 (107), as well as the effect elicited by crosstalk of ET-1 and norepinephrine (8) . Since the positive inotropic effects of these cardiotonic interventions are associated with a shift of the relationship between [Ca 2+ ] i and contractile activity (force or cell shortening), it is postulated that the Ca 2+ sensitization induced by these agents involves cAMP/ PKA-mediated signal transduction. The regulatory proteins that are phosphorylated by PKA, which lead to the Ca 2+ sensitizing mechanism remain to be identified.
The positive inotropic effect of Ca 2+ mobilizers is suppressed under pathophysiological conditions, including acidosis, stunned myocardium, and heart failure. Certain Ca 2+ sensitizers are able to induce an effective positive inotropic effect even under such conditions.
Various processes of cardiac E-C coupling are affected under pathophysiological conditions. For example, acidosis is a major component of cardiac ischemia, which suppresses cardiac contractile function by affecting diverse processes of cardiac E-C coupling, including both Ca 2+ mobilization and Ca 2+ sensitivity as shown with crosses in Fig. 2 (the sizes of crosses imply the extent of influence on individual processes). The conformational changes exerted by Ca 2+ through interaction of troponin C with troponin I play a key role in the acidosis-induced modulation of contractile proteins. The C-terminal domain of troponin I, downstream of the inhibitory peptide, is critical for the inhibitory effect of acidosis on Ca 2+ activation in cardiac myofilaments (113) . When the extracellular pH is lowered from 7.4 to 6.6, a marked dissociation of contractile function from Ca 2+ transients, that is, an increase in Ca 2+ transients in association with a decrease in contractile force is induced (Fig. 3) . This indicates that the decrease in Ca 2+ binding affinity of troponin C plays a predominant role in the influence of acidosis in aequorin-loaded dog ventricular myocardium (111) . Org-30029 elicits a pronounced positive inotropic effect by an increase in myofilament Ca 2+ sensitivity even under acidotic conditions, in which the positive inotropic effect induced by the elevation of [Ca 2+ ] o is markedly suppressed (111) . In contrast, the increase in Ca 2+ sensitivity induced by pimobendan and its active metabolite DD-CG 212 Cl is suppressed under acidotic conditions (112) . While the increase in Ca 2+ sensitivity induced by levosimendan and its active metabolite OR-1896 is essentially unaltered by acidosis, the positive inotropic effect of these compounds is decreased due to an attenuation of the increase in Ca 2+ transients induced by these agents (108, 114, 115) . This indicates that the increase in Ca 2+ transients induced by levosimendan and OR-1896 is more susceptible to acidosis than the increase in myofilament Ca 2+ sensitivity produced by these compounds. Hence, the effectiveness of levosimendan as a cardiotonic agent is markedly decreased by acidosis (115) .
In failing heart, the activation of contractile proteins by intrinsic regulation, including the Frank-Starling mechanism and the force-frequency relationship, as well as external regulation induced by β-adrenoceptor stimulation, deteriorates during the course of congestive heart failure. EMD 57033 is able to increase the contractility by an increase in Ca 2+ sensitivity even when the β-adrenoceptor-mediated positive inotropic effect is markedly decreased in ventricular myocytes isolated from the volume-overload rabbit heart (116).
Conclusion
In intact cardiac muscle, the contractile activity is widely altered by the intrinsic property of cardiac myocytes, such as the Frank-Starling mechanism and the force-frequency relationship. In addition, neurohumoral factors, such as β-and α-adrenoceptor stimulation, ET, Ang, and cytokines, are involved in contractile regulation under various physiological and pathophysiological conditions. Pathophysiological conditions, including acidosis, stunned myocardium, and heart failure, markedly abrogate the intrinsic and neurohumoral regulation. Application of the experimental procedures to simultaneously detect Ca 2+ transients and contractile activity by means of the Ca 2+ sensitive bioluminescent protein aequorin and fluorescent dyes, such as indo-1, provides powerful tools for differentiating the mode of regulation induced by intrinsic and external inotropic interventions in intact cardiac muscle. While the FrankStarling mechanism is associated with only small changes in Ca 2+ transients, the force-frequency relationship is primarily due to an alteration of Ca 2+ transients. The regulatory activities induced by β-and α-adreno- ceptor stimulation are very different between the two mechanisms: the former decreases, but the latter increases Ca 2+ sensitivity. α-Adrenoceptor-mediated regulation is mimicked by endothelin ET A -and angiotensin II AT 1 -receptor stimulation. However, the receptor-mediated regulation of Ca 2+ signaling induced by stimulation of phosphoinositide hydrolysis shows a wide range of species-dependent variation. In addition, α-adrenoceptor stimulation, and ET and Ang II induce a negative inotropic effect in association with a decrease in Ca 2+ transients and Ca 2+ sensitivity in single mouse ventricular myocytes (64) . These agents elicit a positive inotropic effect on Langendorff perfused mouse heart, the mechanism underlying which remains unclear at the moment. Acidosis markedly suppresses the regulative activities induced by Ca 2+ mobilizers, but certain Ca
2+
sensitizers are able to induce an inotropic effect even under such pathophysiological conditions. The experimental procedures to detect Ca 2+ transients simultaneously with contractile activity in intact cardiac muscle and myocytes provide powerful tools for insight into the mode of regulation induced by diverse inotropic interventions under physiological and pathophysiological conditions with respect to Ca 2+ signaling processes.
